Benovus Bio, Inc. Report issue

For profit Phase 1
Founded: Atlanta GA United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2015
NCT02240537
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (3)

bb-mpi-03 (1 trial)

montanide isa 720 (1 trial)

sargramostim (leukine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hematologic Neoplasms (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Multiple Myeloma (Phase 1)

Myelodysplastic Syndromes (Phase 1)

Neoplasms, Plasma Cell (Phase 1)

Smoldering Multiple Myeloma (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 3